Cargando…

Spinal Biologics in Minimally Invasive Lumbar Surgery

As the use of minimally invasive spine (MIS) fusion approaches continues to grow, increased scrutiny is being placed on its outcomes and efficacies against traditional open fusion surgeries. While there are many factors that contribute to the success of achieving spinal arthrodesis, selecting the op...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Kevin Y., Hsu, Wellington K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907390/
https://www.ncbi.nlm.nih.gov/pubmed/29850240
http://dx.doi.org/10.1155/2018/5230350
_version_ 1783315521747288064
author Chang, Kevin Y.
Hsu, Wellington K.
author_facet Chang, Kevin Y.
Hsu, Wellington K.
author_sort Chang, Kevin Y.
collection PubMed
description As the use of minimally invasive spine (MIS) fusion approaches continues to grow, increased scrutiny is being placed on its outcomes and efficacies against traditional open fusion surgeries. While there are many factors that contribute to the success of achieving spinal arthrodesis, selecting the optimal fusion biologic remains a top priority. With an ever-expanding market of bone graft substitutes, it is important to evaluate each of their use as it pertains to MIS techniques. This review will summarize the important characteristics and properties of various spinal biologics used in minimally invasive lumbar surgeries and compare their fusion rates via a systematic review of published literature.
format Online
Article
Text
id pubmed-5907390
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-59073902018-05-30 Spinal Biologics in Minimally Invasive Lumbar Surgery Chang, Kevin Y. Hsu, Wellington K. Minim Invasive Surg Review Article As the use of minimally invasive spine (MIS) fusion approaches continues to grow, increased scrutiny is being placed on its outcomes and efficacies against traditional open fusion surgeries. While there are many factors that contribute to the success of achieving spinal arthrodesis, selecting the optimal fusion biologic remains a top priority. With an ever-expanding market of bone graft substitutes, it is important to evaluate each of their use as it pertains to MIS techniques. This review will summarize the important characteristics and properties of various spinal biologics used in minimally invasive lumbar surgeries and compare their fusion rates via a systematic review of published literature. Hindawi 2018-04-05 /pmc/articles/PMC5907390/ /pubmed/29850240 http://dx.doi.org/10.1155/2018/5230350 Text en Copyright © 2018 Kevin Y. Chang and Wellington K. Hsu. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Chang, Kevin Y.
Hsu, Wellington K.
Spinal Biologics in Minimally Invasive Lumbar Surgery
title Spinal Biologics in Minimally Invasive Lumbar Surgery
title_full Spinal Biologics in Minimally Invasive Lumbar Surgery
title_fullStr Spinal Biologics in Minimally Invasive Lumbar Surgery
title_full_unstemmed Spinal Biologics in Minimally Invasive Lumbar Surgery
title_short Spinal Biologics in Minimally Invasive Lumbar Surgery
title_sort spinal biologics in minimally invasive lumbar surgery
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907390/
https://www.ncbi.nlm.nih.gov/pubmed/29850240
http://dx.doi.org/10.1155/2018/5230350
work_keys_str_mv AT changkeviny spinalbiologicsinminimallyinvasivelumbarsurgery
AT hsuwellingtonk spinalbiologicsinminimallyinvasivelumbarsurgery